Promising fields in the study of the pathogenesis of necrobiosis lipoidica

Abstract

The diagnosis of necrobiosis lipoidica is gaining significance owing to the increase in the incidence of diabetes mellitus. Several theories regarding the etiopathogenesis of necrobiosis lipoidica indicate the distinctive role of transport proteins of the Glut family, as well as the role of matrix metalloproteinase in the development of this dermatosis.

Keywords

necrobiosis lipoidica / diabetes mellitus / Glut / interstitial collagenase

References

[1] Global report on diabetes. Geneva: World Health Organization; 2018. License: CC BY-NC-SA 3.0 IGO

[2] Глобальный доклад по диабету. Женева: ВОЗ; 2018. Лицензия: CC BY-NC-SA 3.0 IGO.

[3] Marchetti F., Gerarduzzi T., Longo F., Faleschini E., Ventura A., Tonini G. Maturity-onset diabetes of the young with necrobiosis lipoidica and granuloma annulare. Pediatric. Dermatol. 2006; 23(3): 247-50.

[4] Marchetti F., Gerarduzzi T., Longo F., Faleschini E., Ventura A., Tonini G. Maturity-onset diabetes of the young with necrobiosis lipoidica and granuloma annulare. Pediatric. Dermatol. 2006; 23(3):247-50.

[5] Lause M., Kamboj A., Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl. Pediatr. 2017; 6(4): 300-12. DOI: 10.21037/tp.2017.09.08

[6] Lause M., Kamboj A., Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl. Pediatr. 2017; 6(4):300-12. doi:10.21037/tp.2017.09.08

[7] Kalamkaryan А.А., Mordovtsev V.N., Trofimova L.Ya. Clinical Dermatology. Rare and Atypical Dermatoses. Yerevan: Ayastan; 1989: 339-42. (in Russian)

[8] Каламкарян А.А., Мордовцев В.Н., Трофимова Л.Я. Клиническая дерматология. Редкие и атипичные дерматозы. Ереван: Айастан; 1989: 339-42.

[9] Teplyuk N.P., Koshelkeva I.V., Plieva L.R., Lepekhova A.A. Total systems oxygen ozone therapy for necrobiosis lipoidica. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei). 2012; 15(2): 35-40. (in Russian)

[10] Теплюк Н.П., Кошелева И.В., Плиева Л.Р., Лепехова А.А. Системная кислородно-озоновая терапия липоидного некробиоза. Российский журнал кожных и венерических болезней. 2012; 15(2): 35-40.

[11] Semenova D.A., Tokmakova A.Yu. Necrobiosis lipoidica in diabetic patients: pathogenetic and clinical features. Diabetes. Russian Journal (Sakharnyy diabet). 2011; (4): 51-4. (in Russian)

[12] Семёнова Д.А., Токмакова А.Ю. Липоидный некробиоз у больных сахарным диабетом: патогенетические и клинические особенности, Сахарный диабет. 2011; (4): 51-4.

[13] de Pablos Vicente M.A., Leal Hernandez M., Balanza Galindo S., Abellan Aleman J. Evaluation of therapeutic inertia in lipid lowering treatment of primary care patients with high cardiovascular risk. Aten. Primaria. 2012; 44(3): e14–5. DOI: 10.1016/j.aprim.2011.02.011

[14] de Pablos Vicente M.A., Leal Hernandez M., Balanza Galindo S., Abellan Aleman J. Evaluation of therapeutic inertia in lipid lowering treatment of primary care patients with high cardiovascular risk. Aten. Primaria. 2012; 44(3): e14--5. DOI: 10.1016/j.aprim.2011.02.011

[15] Petrova G.A., Levin G.Ya. Some indicators of hemorheology in patients with necrobiosis lipoidica. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1989; 65(12):45-8. (in Russian)

[16] Петрова Г.А., Левин Г.Я. Некоторые показатели гемореологии у больных липоидным некробиозом. Вестник дерматологии и венерологии. 1989; 65(12):45-8.

[17] Abramova E.A., Polyanskaya N.P. Сorrelation necrobiosis lipoidica and diabetes. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1985; 61(2):36-8. (in Russian)

[18] Абрамова Е.А. Полянская Н.П. Взаимосвязь липоидного некробиоза с сахарным диабетом. Вестник дерматологии и венерологии. 1985; 61(2):36-8.

[19] Hammer E., Lilienthal E., Hofer S.E., Schulz S., Bollow E., Holl R.W.; DPV Initiative and the German BMBF Competence Network for Diabetes Mellitus. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus. Diabet. Med. 2017; 34(1): 86-92.

[20] Krivosheev A.B. Features of the course of dermatoses in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1988; 63(11): 24-7. (in Russian)

[21] Кривошеев А.Б. Особенности течения дерматозов у больных инсулинзависимым и инсулиннезависимым сахарным диабетом. Вестник дерматологии и венерологии. 1988; 64(11): 24-7.

[22] Butov Yu.S., Iliyena T.A., Vavilov A.M. Clinical and histological signs of necrobiosis lipoidica. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei). 2003; 6(4): 38-42. (in Russian)

[23] Бутов Ю.С., Ильина Т.А., Вавилов А.М. Клинико-гистологические признаки липоидного некробиоза. Российский журнал кожных и венерических болезней. 2003; 6(4):38-42.

[24] Mendes A.L., Miot H.A., Haddad V. Junior. Diabetes mellitus and the skin. An Bras. Dermatol. 2017; 92(1):8-20. DOI: 10.1590/abd1806-4841.20175514

[25] Mendes A.L., Miot H.A., Haddad V. Junior. Diabetes mellitus and the skin. An Bras. Dermatol. 2017; 92(1):8-20. doi:10.1590/abd1806-4841.20175514

[26] Shaposhnikov O.K., Hazizov I.E. Current aspects of the pathogenesis and therapy of granuloma annulare and necrobiosis lipoidica. Bulletin of Dermatology and Venereology (Vestnik dermatologii i venerologii). 1985; (5): 4-8. (in Russian)

[27] Шапошников О.К., Хазизов И.Е. Современные аспекты патогенеза и терапии кольцевидной гранулемы и липоидного некробиоза. Вестник дерматологии и венерологии. 1985; 61(5):4-8.

[28] Krivosheev A.B., Kondratova М.А., Tuguleva Т.А., Morozov D.V. Necrobiosis lipoidica and the metabolic syndrome. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei), 2013; 16(6): 31--6. (in Russian)

[29] Кривошеев А.Б., Кондратова М.А., Тугулева Т.А., Морозов Д.В., Липоидный некробиоз и метаболический синдром. Российский журнал кожных и венерических болезней. 2013; 16(6):31-6.

[30] Holland C., Givens V., Smoller B.R. Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica. J. Cutan. Pathol. 2001; 28(6):287-90.

[31] Stanirowski P.J., Szukiewicz D., Pyzlak M., Abdalla N., Sawicki W., Cendrowski K. Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta. Endocrine. 2017; 55(3):799-808.

[32] Stanirowski P.J., Szukiewicz D., Pazura-Turowska M., Sawicki W., Cendrowski K. Placental expression of glucose transporter proteins in pregnancies complicated by gestational and pregestational diabetes mellitus. Can. J. Diabetes. 2018; 42(2):209-17.

[33] Miele C., Formisano P., Condorelli G., Caruso M., Oriente F., Andreozzi F., et al. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia 1997; 40(4):421-9.

[34] Miele C., Formisano P., Condorelli G., Caruso M., Oriente F., Andreozzi F., et al. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia. 1997; 40(4):421-9.

[35] Saarialho-Kere U.K., Chang E.S., Welgus H.G., Parks W.C. Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. J. Invest. Dermatol. 1993; 100(3):335-42.

[36] Kochet К.А. Features of epidemiology and clinical manifestations in patients with necrobiosis lipoidica. Dermatology and Venereology (Dermatolohiya ta Venerolohiya). 2017; 4(78): 47-51. (in Ukraine)

[37] Кочет К.А. Особенности эпидемиологии и клинических проявлений у пациентов с липоидным некробиозом. Дерматологiя та Венерологiя. 2017; 4(78):47-51.

[38] Pellicano R., Caldarola G., Filabozzi P., Zalaudek I. Dermoscopy of necrobiosis ipoidica and granuloma annulare. Dermatology. 2013; 226(4):319-23.

[39] Pellicano R., Caldarola G., Filabozzi P., Zalaudek I. Dermoscopy of necrobiosis ipoidica and granuloma annulare. Dermatology. 2013; 226(4): 319-23.

[40] Gadzhimuradov М.N., Asadulaeva Z.G. Clinical features of necrobiosis lipoidica. Clinical Dermatology and Venereology. Russian Journal (Klinicheskaya dermatologiya i venerologiya). 2016; 15(4):32-5. (in Russian)

[41] Гаджимурадов М.Н., Асадулаева З.Г. Клинические особенности липоидного некробиоза. Клиническая дерматология и венерология. 2016; 15(4):32-5.

[42] Souza F.H., Ribeiro C.F., Pereira M.A., Mesquita L., Fabrício L. Simultaneous occurrence of ulcerated necrobiosis lipoidica and granuloma annulare in a patient: case report. An Bras. Dermatol. 2011; 86(5):1007-10.

[43] Wee E., Kelly R. Pentoxifylline: An effective therapy for necrobiosis lipoidica. Australas J. Dermatol. 2017; 58(1):65-8. DOI: 10.1111/ajd.12420.

[44] Wee E., Kelly R. Pentoxifylline: An effective therapy for necrobiosis lipoidica. Australas J. Dermatol. 2017; 58(1):65-8. doi: 10.1111/ajd.12420.

[45] Gualdi G., Monari P., Farisoglio C., Calzavara-Pinton P. Juvenile ulcerated necrobiosis lipoidica successfully treated with oral cyclosporin A. G. Ital. Dermatol. Venereol. 2013; 148(6): 703-4.

[46] Gualdi G., Monari P., Farisoglio C., Calzavara-Pinton P. Juvenile ulcerated necrobiosis lipoidica successfully treated with oral cyclosporin A. G. Ital. Dermatol. Venereol. 2013; 148(6):703-4.

[47] Shah S.D., Kale G.V. Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with oral thalidomide. Indian Dermatol. Online J. 2016; 7(1):43-5.

[48] Eberle F.C., Ghoreschi K., Hertl M. Fumaric acid esters in severe ulcerative necrobiosis lipoidica: a case report and evaluation of current therapies. Acta Derm. Venereol. 2010; 90(1):104-6.

[49] Kreuter A., Knierim C., Stucker M., Pawlak F., Rotterdam S., Altmeyer P., Gambichler T. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Br. J. Dermatol. 2005; 153(4):802-7.

[50] Kavala M., Sudogan S., Zindanci I., Kocaturk E., Can B., Turkoglu Z., Altintas S. Significant improvement in ulcerative necrobiosis lipoidica with hydroxychloroquine. Int. J. Dermatol. 2010; 49(4):467-9.

[51] Narbutt J., Torzecka J.D., Sysa-Jedrzejowska A., Zalewska A. Long-term results of topical PUVA in necrobiosis lipoidica. Clin. Exp. Dermatol. 2006; 31(1):65-7.

[52] Attili S.K., Dawe R.S., Ibbotson S.H. Ultraviolet A1 phototherapy: One center’s experience. Indian J. Dermatol. Venereol. Leprol. 2017; 83(1):60-5.

[53] Radakovic S., Weber M., Tanew A. Dramatic response of chronic ulcerating necrobiosis lipoidica to ultraviolet A1 phototherapy. Photodermatol. Photoimmunol. Photomed. 2010; 26(6):327-9.

[54] Basoulis D., Fragiadaki K., Tentolouris N., Sfikakis P.P., Kokkinos A. Anti-TNFalpha treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature. Metabolism. 2016; 65(4): 569--73.

[55] Basoulis D., Fragiadaki K., Tentolouris N., Sfikakis P.P., Kokkinos A. Anti-TNFalpha treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature. Metabolism. 2016; 65(4):569-73.

[56] Guedes R., Leite I., Baptista A., Rocha N. Ulcerative necrobiosis lipoidica: is there a place for anti-TNFalpha treatment? Case Rep. Med. 2012; 2012: 854738.

[57] Guedes R., Leite I., Baptista A., Rocha N. Ulcerative necrobiosis lipoidica: is there a place for anti-TNFalpha treatment? Case Rep. Med. 2012; 2012:854738.

[58] Suarez-Amor O., Perez-Bustillo A., Ruiz-Gonzalez I., Rodriguez-Prieto M.A. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010; 221(2): 117--21.

[59] Suarez-Amor O., Perez-Bustillo A., Ruiz-Gonzalez I., Rodriguez-Prieto M.A. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology. 2010; 221(2):117-21.

[60] Peckruhn M., Tittelbach J., Elsner P. Update: Treatment of necrobiosis lipoidica. J. Deutsch. Dermatol. Ges. 2017; 15(2): 151--7. https://doi.org/10.1111/ddg.13186.

[61] Peckruhn M., Tittelbach J., Elsner P. Update: Treatment of necrobiosis lipoidica. J. Deutsch. Dermatol. Ges. 2017; 15(2): 151-7. https://doi.org/10.1111/ddg.13186.

[62] Bonura C., Frontino G., Rigamonti A., Battaglino R., Favalli V., Ferro G., et al. Necrobiosis lipoidica diabeticorum: A pediatric case report. Dermatoendocrinol. 2014; 6(1): e27790.

[63] Bonura C., Frontino G., Rigamonti A., Battaglino R., Favalli V., Ferro G., et al. Necrobiosis lipoidica diabeticorum: A pediatric case report. Dermatoendocrinol. 2014; 6(1):e27790.

RIGHTS & PERMISSIONS

Eco-Vector